Personal tools

MCL coexpression mm9:980: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0001017!9.19e-36!73;UBERON:0001016!5.36e-35!75;UBERON:0000073!2.63e-31!54;UBERON:0002346!1.39e-30!64;UBERON:0003075!1.39e-30!64;UBERON:0007284!1.39e-30!64;UBERON:0001049!2.12e-29!52;UBERON:0005068!2.12e-29!52;UBERON:0006241!2.12e-29!52;UBERON:0007135!2.12e-29!52;UBERON:0004121!4.27e-29!95;UBERON:0000924!4.27e-29!95;UBERON:0006601!4.27e-29!95;UBERON:0000955!3.82e-25!47;UBERON:0006238!3.82e-25!47;UBERON:0002616!1.99e-24!46;UBERON:0010371!7.05e-24!73;UBERON:0003056!7.40e-24!49;UBERON:0003080!5.70e-23!40;UBERON:0002780!3.91e-22!39;UBERON:0001890!3.91e-22!39;UBERON:0006240!3.91e-22!39;UBERON:0010314!4.67e-21!92;UBERON:0002020!1.45e-19!34;UBERON:0003528!8.60e-16!29;UBERON:0002791!8.60e-16!29;UBERON:0001893!8.60e-16!29;UBERON:0000956!1.77e-10!21;UBERON:0001869!1.77e-10!21;UBERON:0000203!1.77e-10!21;UBERON:0002619!6.29e-09!17;UBERON:0002021!1.04e-07!10;UBERON:0000411!1.04e-07!10;UBERON:0001950!1.04e-07!10;UBERON:0001894!2.72e-07!10;UBERON:0006222!2.72e-07!10;UBERON:0003076!7.11e-07!12;UBERON:0003057!7.11e-07!12
|ontology_enrichment_uberon=UBERON:0001017!9.19e-36!73;UBERON:0001016!5.36e-35!75;UBERON:0000073!2.63e-31!54;UBERON:0002346!1.39e-30!64;UBERON:0003075!1.39e-30!64;UBERON:0007284!1.39e-30!64;UBERON:0001049!2.12e-29!52;UBERON:0005068!2.12e-29!52;UBERON:0006241!2.12e-29!52;UBERON:0007135!2.12e-29!52;UBERON:0004121!4.27e-29!95;UBERON:0000924!4.27e-29!95;UBERON:0006601!4.27e-29!95;UBERON:0000955!3.82e-25!47;UBERON:0006238!3.82e-25!47;UBERON:0002616!1.99e-24!46;UBERON:0010371!7.05e-24!73;UBERON:0003056!7.40e-24!49;UBERON:0003080!5.70e-23!40;UBERON:0002780!3.91e-22!39;UBERON:0001890!3.91e-22!39;UBERON:0006240!3.91e-22!39;UBERON:0010314!4.67e-21!92;UBERON:0002020!1.45e-19!34;UBERON:0003528!8.60e-16!29;UBERON:0002791!8.60e-16!29;UBERON:0001893!8.60e-16!29;UBERON:0000956!1.77e-10!21;UBERON:0001869!1.77e-10!21;UBERON:0000203!1.77e-10!21;UBERON:0002619!6.29e-09!17;UBERON:0002021!1.04e-07!10;UBERON:0000411!1.04e-07!10;UBERON:0001950!1.04e-07!10;UBERON:0001894!2.72e-07!10;UBERON:0006222!2.72e-07!10;UBERON:0003076!7.11e-07!12;UBERON:0003057!7.11e-07!12
|tfbs_overrepresentation_for_novel_motifs=1.01838,2.6876,0.367606,0.434198,0.720982,0.448401,0.538088,0.515265,1.02512,1.50457,0.494602,0.526159,1.57591,0.550255,0.275867,0,0.742571,0.252772,0.160384,0.620214,0.332107,0.0622758,0.549359,0.258745,0.374936,0.577606,1.45743,0.469052,1.48474,0.376624,0.455168,1.96654,0.250677,0.136998,2.13031,0.60397,0.678971,0.522578,0.221921,2.41256,0.256422,0.460258,0.450632,0.27776,0.403938,0.423266,0.662995,0.484612,0.170971,0.825035,0.725127,0.604356,0.362495,0.985264,1.00271,1.37128,0.314394,0.513517,0.447041,0.555328,0.823643,0.613749,0.192045,0.713876,0.568415,0.754324,1.139,1.48833,0.818971,1.34113,0.922232,1.0125,0.50864,1.03623,0.140213,0.131016,0.42492,0.651651,0.806481,0.336166,0.179489,0.759925,0.612313,0.501608,0.920903,2.55025,0.0299392,0.118251,0.667883,1.65055,1.20871,0.925879,0.856465,0.265734,0.218233,0.202284,0.1711,0.859272,0.663249,0.101559,0.242106,0.843387,0.967837,0.725721,0.724668,0.459825,0.784351,0.480639,0.340849,1.59446,0.386136,0.96962,4.34722,0.499714,1.21576,0.254749,3.5137,0.437894,0.743872,0.238599,1.04163,0.692953,0.579418,0.650748,1.26989,0.810177,1.34763,0.849691,1.13749,0.268537,0.950857,0.427043,1.10792,0.570914,1.23736,0.479867,1.03631,1.16726,1.18819,2.01886,1.6187,1.14372,0.591394,0.854131,0.718197,0.460705,0.666107,1.9792,1.04134,1.33415,4.74015,0.780212,0.986833,0.207643,0.569994,1.06851,0.605358,0.287226,0.39061,0.400939,1.1977,0.920047,0.810622,0.383936,0.714896,0.562634,0.676555,0.524587,0.331912
}}
}}

Revision as of 19:12, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr1:134530782..134530799,-p@chr1:134530782..134530799
-
Mm9::chr1:75252424..75252442,-p@chr1:75252424..75252442
-
Mm9::chrX:7497133..7497146,+p@chrX:7497133..7497146
+
Mm9::chrX:7499420..7499445,+p@chrX:7499420..7499445
+
Mm9::chrX:7499446..7499477,+p@chrX:7499446..7499477
+
Mm9::chrX:7499494..7499535,+p@chrX:7499494..7499535
+
Mm9::chrX:7499540..7499554,+p@chrX:7499540..7499554
+
Mm9::chrX:7500068..7500101,+p@chrX:7500068..7500101
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
central nervous system9.19e-3673
nervous system5.36e-3575
regional part of nervous system2.63e-3154
neurectoderm1.39e-3064
neural plate1.39e-3064
presumptive neural plate1.39e-3064
neural tube2.12e-2952
neural rod2.12e-2952
future spinal cord2.12e-2952
neural keel2.12e-2952
ectoderm-derived structure4.27e-2995
ectoderm4.27e-2995
presumptive ectoderm4.27e-2995
brain3.82e-2547
future brain3.82e-2547
regional part of brain1.99e-2446
ecto-epithelium7.05e-2473
pre-chordal neural plate7.40e-2449
anterior neural tube5.70e-2340
regional part of forebrain3.91e-2239
forebrain3.91e-2239
future forebrain3.91e-2239
structure with developmental contribution from neural crest4.67e-2192
gray matter1.45e-1934
brain grey matter8.60e-1629
regional part of telencephalon8.60e-1629
telencephalon8.60e-1629
cerebral cortex1.77e-1021
cerebral hemisphere1.77e-1021
pallium1.77e-1021
regional part of cerebral cortex6.29e-0917
occipital lobe1.04e-0710
visual cortex1.04e-0710
neocortex1.04e-0710
diencephalon2.72e-0710
future diencephalon2.72e-0710
posterior neural tube7.11e-0712
chordal neural plate7.11e-0712


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}